Crowdonomics
All companies

ENDONOVO THERAPEUTICS, INC.

Public

Healthcare · Woodland Hills, CA

Estimated pre-money ⓘ
$2.0M
As of Feb 2022 · from Reg A Offering (2022) · our estimate: offering price × shares outstanding, not a stated valuation
Total raised
$1,786,750
Crowd $0 · Private $1.8M · 8 rounds since 2013
Latest share price
$0.025
Reg A Offering (2022) offering price

Financials

FY2010–FY2022 · from SEC filings · hover any figure for its source
$4K
−$6.8M
2015
−$5.3M
2016
−$10.8M
2017
$83K
−$6.4M
2018
$310K
−$17.3M
2019
$166K
−$396K
2020
$73K
−$3.1M
2021
$135K
−$18.5M
2022
RevenueNet income — beside revenue when positive, below the line when a loss

Chart shows the most recent 8 fiscal years; 5 earlier years are in the table below.

Metric
FY2010 audited
FY2011 audited
FY2012 audited
FY2013 audited
FY2014 audited
FY2015 audited
FY2016 audited
FY2017 audited
FY2018 audited
FY2019 audited
FY2020 audited
FY2021 audited
FY2022 audited
Income statement
Revenue
$51,199
$45,544
$30,581
$22,896
$24,192
$4,265
—
—
$83,263
$310,164
$165,796
$73,105
$135,355
Cost of goods sold
—
—
—
$13,993
$15,485
$2,162
—
—
$12,930
$93,385
$65,369
$14,985
$9,990
Gross margin
—
—
—
39%
36%
49%
—
—
84%
70%
61%
80%
93%
Net income
-$69,400
-$94,088
-$1,914,551
-$2,892,794
-$959,494
-$6,765,736
-$5,315,672
-$10,810,160
-$6,435,839
-$17,314,504
-$395,584
-$3,104,894
-$18,474,835
Taxes paid
$800
$800
$0
$532
$0
$0
—
—
—
—
—
—
—
Balance sheet
Cash
$34,772
$69,718
$800
$3,255
$988
$41,473
$55,533
$90,173
$379,151
$18,893
$13,420
$85,936
$98
Accounts receivable
$0
$1,372
$4,954
—
—
—
—
—
$3,345
$22,742
$942
$944
$0
Total assets
$167,950
$73,255
$2,164
$73,593
$45,589
$409,363
$318,679
$4,612,237
$4,242,313
$3,274,650
$2,607,035
$2,007,211
$1,281,266
Short-term debt
—
$175,000
$236,000
$604,416
$1,096,602
$12,031
$12,395
$4,221
$6,054,403
$6,697,146
$6,491,039
$7,055,030
$7,041,145
Long-term debt
—
—
—
—
$1,572,688
$28,647
$3,193,656
$7,356,144
$8,158,198
$6,874,795
$6,835,196
$7,256,930
$7,153,245
Total liabilities
—
$1,440,798
$0
$4,205,806
$4,738,594
$9,685,423
$8,880,545
$14,162,537
$15,634,151
$23,778,470
$16,980,821
$17,781,535
$33,461,585
Other
Headcount
—
—
—
—
—
—
—
—
—
—
0
0
0

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$2.0M
est. pre-money
Reg A+ · Equity · Feb 2022

Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.

Cap table

Share counts as of Sep 30, 2023
preferred stock · 0%Common stock · 100.0%
ClassOutstandingVotes / shareShare of totalLast price
preferred stockpreferred738—0%—
Common stock318,751,597—100.0%—
Total318,752,335100%

Shares outstanding over timein today's share terms

560M280M0
Mar 2015Sep 2023
Common stockpreferred stockRound openedSplit / conversion

Changes in named holdersshares in today's terms · % of all shares at the time

Principal holders% as the filing states it, Aug 25, 2023

  • James Greenland20,175,000 shares7.5%of company
  • Michael Mann13,525,437 shares5%of company

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Reg A+ · Equity · Feb 2022Closedvia DALMORE GROUP LLC
Raised $0 / $5MEst. pre-money $2M
Raised $225KInvestors 4
Raised $700KInvestors 13
Raised $211.3KInvestors 6
Raised $105KInvestors 3
Raised $12.5KInvestors 1
Raised $50KInvestors 2
Raised $483KInvestors 19

Team

1 person
Alan Collier
Director, Chief Executive Officer, Interim Chief Financial Officer, and Secretary

Names and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.

  • Form 10-QDec 29, 20230001493152-23-046444
    EDGAR
  • Form 10-Q/ADec 29, 20230001493152-23-046561
    EDGAR
  • Form 1-A/AAug 25, 20230001493152-23-030138
    EDGAR
  • Form 10-QAug 21, 20230001493152-23-029706
    EDGAR
  • Form 1-A/AJun 14, 20230001493152-23-021216
    EDGAR
  • Form 10-QMay 22, 20230001493152-23-018538
    EDGAR
  • Form 10-KApr 17, 20230001493152-23-012553
    EDGAR
  • Form 10-QNov 21, 20220001493152-22-033118
    EDGAR
Source: SEC EDGARCIK 0001528172DEShare price $0.025Last synced Aug 16, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.